Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron Premedication in Juvenile Idiopathic Arthritis
NCT04169828Completed
- Sponsor
- University of British Columbia
- Start
- Aug 2019
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ondansetron in juvenile idiopathic arthritis (JIA), nausea ((none)) and Vomiting (2 arms), sponsored by University of British Columbia. Primary endpoint: Proportion of subjects that remain on methotrexate with no intolerance at 1 year. Started Aug 2019; status: completed.
02
Drugs
ondansetron
03
Conditions
juvenile idiopathic arthritis (JIA)nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT04169828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04169828.